[CNP_O5] Oral Session 5

Fri. Oct 11, 2019 10:30 AM - 12:10 PM Room 10 (406)

座長：新開　隆弘（産業医科大学医学部精神医学教室）

+Add all to schedule

10:30 AM - 10:50 AM

[CNP-O5-1] Administration of aripiprazole to a schizophrenia patient with congenital QT interval prolongation. -A case report-

^○Hitoshi IKEDA, Ayaka TAMURA, Masahiro MATSUO, Yuji OZEKI (Department of Psychiatry, Shiga University of Medical Science)

10:50 AM - 11:10 AM

[CNP-O5-2] ”D-cell hypothesis of schizophrenia" shows molecular basis of progressive pathology of schizophrenia

^○Keiko IKEMOTO (Department of Psychiatry, Iwaki City Medical Center)

11:10 AM - 11:30 AM

[CNP-O5-3] Analyses of metabolites related to glutamate in serum of antipsychotic-naïve individuals with Early Psychosis

^○Hiromi TAGATA¹, Naohisa TSUJINO^{1, 2}, Mayu ONOZATO³, Tatsuya SAKAMOTO³, Tomoyuki FUNATOGAWA¹, Taiju YAMAGUCHI¹, Naoyuki KATAGIRI¹, Takahiro NEMOTO¹, Takeshi FUKUSHIMA³, Masafumi MIZUNO¹ (1. Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan　　　　, 2. Saiseikai Yokohamashi Tobu Hospital, 3. Faculty of Pharmaceutical Sciences, Toho University)

11:30 AM - 11:50 AM

[CNP-O5-4] One-year clinical course in cases receiving clozapine discontinuation: A retrospective chart review

^○Maiko WATANABE¹, Fuminari MISAWA¹, Yasuo FUJII¹, Hiroyoshi TAKEUCHI² (1. Yamanashi Prefectural KITA Hospital, 2. Department of Neuropsychiatry, School of Medicine, Keio University)